drugset / Trial / NCT05628857
A Study of RC108-ADC in Subjects With Advanced Digestive System Malignant Tumor
Non-randomizedParallel-groupOpen-labelTreatment
Summary
A multi-center, open-label, study designed to evaluate the preliminary efficacy, safety and pharmacokinetics of RC108 in patients with c-Me-positive advanced digestive system malignancies.
Timeline
- Start
- 2022-11-11
- Primary completion
- 2025-12-31
- Completion
- 2025-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | RC108 | Other / unclassified | — | Intravenous |